Editorial: Sirtuinome Rewiring to Hijack Cancer Cell Behavior and Hamper Resistance to Anticancer Intervention

Editorial: Sirtuinome Rewiring to Hijack Cancer Cell Behavior and Hamper Resistance to Anticancer Intervention

Bibliographic Details
Main Authors:	Stefano Falone, Athanassios Vassilopoulos, Lucia Altucci
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Oncology
Subjects:	sirtuins cancer chemoresistance malignant phenotype chemotherapy tumor
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.01242/full

Similar Items

The human sirtuin family: Evolutionary divergences and functions
by: Vassilopoulos Athanassios, et al.
Published: (2011-07-01)

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation
by: Sathid Aimjongjun, et al.
Published: (2019-11-01)

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance
by: QingYi Zhao, et al.
Published: (2022-06-01)

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
by: Dimas Carolina Belisario, et al.
Published: (2020-12-01)

Anticancer Agents Targeted to Sirtuins
by: Tomohiro Kozako, et al.
Published: (2014-12-01)

Misdiagnosis and Chemotherapy Delaying Reduces the Chemosensitivity of Choriocarcinoma Patient: Analysis of 36 Cases
by: Lin-Jing Yuan, et al.
Published: (2022-07-01)

Mechanisms Involved in Chemoresistance in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01)

Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
by: Vincenzo Carafa, et al.
Published: (2019-01-01)

Sirtuins & disease: the road ahead
by: Vincenzo eCarafa, et al.
Published: (2012-01-01)

Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy
by: Armel Hervé Nwabo Kamdje, et al.
Published: (2024-09-01)

Editorial: Molecular basis of epigenetic regulation in cancer therapies
by: Angeles Carlos-Reyes, et al.
Published: (2023-01-01)

Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
by: Lianbo Li
Published: (2022-08-01)

Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids
by: Isabel S. Sagheb, et al.
Published: (2024-09-01)

Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action
by: Sebastiano Masuri, et al.
Published: (2021-12-01)

Evaluation of targeting autophagy for the treatment of malignant rhabdoid tumours
by: Patricia Hannon Barroeta, et al.
Published: (2022-01-01)

Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial
by: Sergei Krasny, et al.
Published: (2024-02-01)

Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma
by: Rongkun Chen, et al.
Published: (2024-04-01)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma
by: Tingting Chen, et al.
Published: (2022-10-01)

Identification of therapeutically potential targets and their ligands for the treatment of OSCC
by: Pratima Kumari, et al.
Published: (2022-09-01)

Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes
by: Che Liu, et al.
Published: (2017-06-01)

Context-Dependent Roles for SIRT2 and SIRT3 in Tumor Development Upon Calorie Restriction or High Fat Diet
by: Mohamed A. Ahmed, et al.
Published: (2020-01-01)

Starting points for the development of new targeted therapies for glioblastoma multiforme
by: Agnieszka Rusak, et al.
Published: (2025-01-01)

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
by: Wenrong Mu, et al.
Published: (2023-11-01)

The effect of anticancer treatment on cancer patients with COVID‐19: A systematic review and meta‐analysis
by: Hanqing Liu, et al.
Published: (2021-02-01)

SIRT1 Activation by Natural Phytochemicals: An Overview
by: Concetta Iside, et al.
Published: (2020-08-01)

DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma
by: Qing‐Jie Li, et al.
Published: (2024-09-01)

Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
by: Jingjing Sha, et al.
Published: (2021-06-01)

The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer
by: Weilu Wu, et al.
Published: (2023-08-01)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
by: Andreas Venizelos, et al.
Published: (2022-08-01)

Assessing chemotherapy dosing strategies in a spatial cell culture model
by: Dhruba Deb, et al.
Published: (2022-11-01)

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer
by: San-Jian Yu, et al.
Published: (2018-01-01)

Role of Ginseng, Quercetin, and Tea in Enhancing Chemotherapeutic Efficacy of Colorectal Cancer
by: Linxian Zhao, et al.
Published: (2022-06-01)

Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells
by: Bin Shang, et al.
Published: (2017-04-01)

3,3′-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen species
by: Susan Lanza-Jacoby, et al.
Published: (2018-01-01)

Commentary: Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
by: Giovanni Li Volti, et al.
Published: (2017-06-01)

Role of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3
by: Fatiha Nassir
Published: (2020-08-01)

Expert opinion on translational research for advanced glioblastoma treatment
by: Xiaoteng Cui, et al.
Published: (2023-05-01)

Editorial: Regulation of metabolic rewiring in T-cell malignancies
by: Santosh Kumar, et al.
Published: (2024-03-01)

Sirtuin activators as an anti-aging intervention for longevity
by: Puja Sah, et al.
Published: (2025-01-01)

The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?
by: Lin Zhang, et al.
Published: (2020-09-01)